Robert C. Pallash net worth and biography

Robert Pallash Biography and Net Worth

Director of FMC

Until December 2013, Mr. Pallash served as President, Global Customer Group and Senior Vice President of Visteon Corporation, an automotive parts manufacturer, since January 2008. From August 2005 to January 2008, Mr. Pallash was Senior Vice President, Asia Customer Group for Visteon. He joined Visteon in September 2001 as Vice President, Asia Pacific. Visteon filed for bankruptcy protection under Chapter 11 of the U.S. Bankruptcy Code in May 2009 and exited in October 2010. Prior to joining Visteon, Mr. Pallash served as President of TRW Automotive Japan from 1999. Mr. Pallash is a member of the Board of Directors of Livent Corporation. Previously, he served on the Board of Directors of Halla Climate Controls in South Korea, a majority-owned subsidiary of Visteon Corporation.

What is Robert C. Pallash's net worth?: The estimated net worth of Robert C. Pallash is at least $2.80 million as of November 27th, 2023. Mr. Pallash owns 47,871 shares of FMC stock worth more than $2,798,539 as of April 27th. This net worth evaluation does not reflect any other investments that Mr. Pallash may own. Learn More about Robert C. Pallash's net worth.
How do I contact Robert C. Pallash?: The corporate mailing address for Mr. Pallash and other FMC executives is 2929 WALNUT STREET, PHILADELPHIA PA, 19104. FMC can also be reached via phone at (215) 299-6000 and via email at [email protected]. Learn More on Robert C. Pallash's contact information.
Has Robert C. Pallash been buying or selling shares of FMC?: Robert C. Pallash has not been actively trading shares of FMC within the last three months. Most recently, on Monday, November 27th, Robert C. Pallash bought 3,845 shares of FMC stock. The stock was acquired at an average cost of $52.48 per share, with a total value of $201,785.60. Following the completion of the transaction, the director now directly owns 47,871 shares of the company's stock, valued at $2,512,270.08. Learn More on Robert C. Pallash's trading history.
Who are FMC's active insiders?: FMC's insider roster includes Eduardo Cordeiro (Director), Carol Davidson (Director), Mark Douglas (CEO), Robert Pallash (Director), Ronaldo Pereira (EVP), Nicholas Pfeiffer (Insider), Michael Reilly (EVP), and Andrew Sandifer (CFO). Learn More on FMC's active insiders.
Are insiders buying or selling shares of FMC?: During the last twelve months, FMC insiders bought shares 5 times. They purchased a total of 13,108 shares worth more than $1,031,402.77. The most recent insider tranaction occured on March, 4th when CFO Andrew D Sandifer bought 2,150 shares worth more than $127,323.00. Insiders at FMC own 0.9% of the company. Learn More about insider trades at FMC.
Information on this page was last updated on 3/4/2024.

Robert C. Pallash Insider Trading History at FMC

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/27/2023	Buy	3,845	$52.48	$201,785.60	47,871
2/20/2019	Sell	6,992	$87.28	$610,261.76	37,458

Robert C. Pallash Buying and Selling Activity at FMC

FMC Company Overview

FMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that includes insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control. The company markets its products through its own sales organization and through alliance partners, independent distributors, and sales representatives. It operates in North America, Latin America, Europe, the Middle East, Africa, and Asia. The company was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.

Today's Range

Now: $58.46

$57.31

$58.79

50 Day Range

MA: $59.45

$50.99

$66.06

2 Week Range

Now: $58.46

$49.49

$124.61

Volume

942,800 shs

Average Volume

1,485,117 shs

Market Capitalization

$7.30 billion

P/E Ratio

5.55

Dividend Yield

4.01%

Beta

0.87

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>